SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-23-005679
Filing Date
2023-09-12
Accepted
2023-09-12 16:30:21
Documents
14
Period of Report
2023-09-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_091123.htm   iXBRL 8-K 28790
2 EXHIBIT 10.1 exh_101.htm EX-10.1 268445
3 EXHIBIT 10.2 exh_102.htm EX-10.2 109336
  Complete submission text file 0001171843-23-005679.txt   661827

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE apto-20230906.xsd EX-101.SCH 3030
5 XBRL LABEL FILE apto-20230906_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE apto-20230906_pre.xml EX-101.PRE 22369
8 EXTRACTED XBRL INSTANCE DOCUMENT f8k_091123_htm.xml XML 3306
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 231250467
SIC: 2836 Biological Products, (No Diagnostic Substances)